Journal
MEDICAL MYCOLOGY CASE REPORTS
Volume 32, Issue -, Pages 64-67Publisher
ELSEVIER
DOI: 10.1016/j.mmcr.2021.03.006
Keywords
Invasive; Pulmonary; Mucormycosis; Aspergillosis; COVID-19
Categories
Ask authors/readers for more resources
Invasive pulmonary mucormycosis and aspergillosis are rare and life-threatening fungal infections, often seen in patients with diabetes, neutropenia, or corticosteroid use. These infections are recognized as secondary complications of COVID-19, particularly in critically ill patients. This report presents the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, especially among critically ill patients. We report the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available